Category Archives: Neuroscience

Neuroscience

University of Miami Miller School Plays Pivotal Role in Securing a $15 Million National Alzheimers Disease Research Center – Newswise

Newswise University of Miami Miller School of Medicine investigators play a pivotal role in a consortium of Florida institutions just awarded a $15 million grant to collaborate on Alzheimers disease research.

The five-year National Institutes of Health/National Institute on Aging grant brings together top Florida researchers to focus on better understanding how to diagnose, treat, prevent, and potentially cure Alzheimers in diverse populations.

The 1Florida Alzheimers Disease Research Center, or1Florida ADRC, will be recruiting participants from the University of Miami Miller School of Medicine, the University of Florida, and Mount Sinai Medical Center in Miami Beach. Investigators from these institutions will also be collaborating other Florida academic institutions including Florida Atlantic University and Florida International University.

We are honored that this Alzheimers Disease Research Center is one of 31 centers of excellence designated by the National Institute on Aging. Of the 31 centers in the U.S., the 1Florida ADRC is the only funded center in Florida, said David Loewenstein, Ph.D., ABPP/CN, associate director of 1Florida ADRC and director of the Center for Cognitive Neuroscience and Aging (CNSA) at the Miller School.

Miller School researchers are involved in all aspects of the 1Florida ADRC, including recruitment, onsite evaluation, and research. Dr. Loewenstein is leading the Miller School investigative team. Other UM researchers include Rosie E. Curiel Cid, Psy.D., leader of the1Florida ADRC Outreach, Recruitment and Engagement Core, associate professor and chief, cross-cultural neuropsychology and cognitive neuroscience, in the Center for Cognitive Neuroscience and Aging; Elizabeth Crocco, M.D., chief of geriatric psychiatry and director of UMs state-funded Memory Disorders Clinic and medical director of the CNSA, who will be running the medical aspects of the 1Florida ADRC; and Tatjana Rundek, M.D., Ph.D., professor of neurology and Evelyn F. McKnight Endowed Chair for Learning and Memory in Aging, who is co-leading the ADRCs educational core with Glenn Smith, Ph.D., ABPP/CN, from the University of Florida.

The Miller School is recruiting hundreds of older adults from our local community, said Dr. Loewenstein. Their focus is on engaging African American and Hispanic older adults to make sure they are well represented, because these groups are historically largely under-represented in aging research, including studies looking at Alzheimers disease.

I am the daughter of Cuban exiles; the first to be born in this country. Spanish was my first language. Miami has nurtured this multicultural identity and I am privileged to bring it to the forefront of my work, Dr. Curiel said. One of the greatest challenges in aging research is ensuring that the methods we develop to detect and treat diseases of the aging brain are generalizable toallolder adults. The CNSA is committed to addressing this by developing tools and methods that are cross-culturally applicable. Now, the 1Florida ADRC will significantly broaden our reach. We assembled a passionate team of scientists from diverse cultural backgrounds to engage, educate, listen to, and partner with our richly diverse communities. We hope to generate new knowledge and contribute to national efforts to accelerate clinically meaningful outcomes for older adults and their families.

To better understand diseases of the aging brain, even decades before they occur, the ADRC scientists have an expertise in studying people who dont yet have symptoms but might be concerned about their risk for developing Alzheimers for another reason, such as family history. They also study older adults who may have thinking or memory problems but havent yet been diagnosed, as well as people who have been diagnosed with early mild cognitive impairment.

People in the study will receive annual evaluations including comprehensive neuropsychological testing, a careful clinical examination, an MRI scan of the brain and an amyloid scan, Dr. Loewenstein said. We will follow them on an annual basis.

Dr. Loewenstein and colleagues at the Miller School developed a novel cognitive stress test, called the Loewenstein-Acevedo Scales for Semantic Interference and Learning (LASSI-L) test, which will be used in the 1Florida ADRC study. LASSI-L is a scientifically proven measure that is highly sensitive to early Alzheimers disease brain pathology and can pick up early changes in memory before traditional cognitive testing detects the disease.

The Miller School also stands out for being the only university in the state funded by the NIH to conduct tau imaging. Miller School researchers have a number of federally funded grants that are studying abnormal tau protein in the brain. The presence of amyloid alone is not the only indication of future Alzheimers disease. Some people start to show signs of tau deposition years, even decades, before developing symptoms.

The University of Miami Miller School of Medicine brings something very special to the table and that is why we were asked to be a major part of this initiative. It was because of our strengths in novel cognitive testing, neuroimaging and ability to engage and recruit persons from diverse cultures, Dr. Loewenstein said.

The 1Florida ADRC will also help to train the next generation of scientists in Alzheimers and other neurodegenerative diseases. Dr. Rundek said the ADRCs Research Education Component, called 1Florida Alzheimer's Disease Science Training to Advance Research Success, or AlzSTARS, will train diverse, multidisciplinary early stage investigators at all participating institutions for leadership roles in research translation, especially in regard to diverse and underserved communities.

The AlzSTARS program will provide a unique opportunity for our young trainees from diverse backgrounds to train with clinical and research leaders in Alzheimers disease across Florida and the nation. They will become the next generation of leaders and scientists to successfully translate scientific discoveries to prevention and treatment of Alzheimers disease, Dr. Rundek said.

Dr. Crocco, who has devoted more than 22 years to working with South Floridas older population affected by Alzheimers disease, will also offer her expertise in Alzheimers disease and related disorders to the 1Florida ADRC Clinical Core.

The ADRC brings us to the level of a national center of excellence, Dr. Crocco said. We have the funding and the ability now to be able to promote and really develop more and more these wonderful diagnostic strategies, treatment strategies and, hopefully, one day a cure for Alzheimers disease and other neurodegenerative disorders.

Florida is home to about 12% of the approximately 5.4 million people in the U.S. who have Alzheimers disease. For more information about 1Florida ADRC including how to participate, visitwww.1floridaadrc.org, emailinfo@1floridaadrc.orgor call 352-273-7425 or 305-355-9080.

Continued here:
University of Miami Miller School Plays Pivotal Role in Securing a $15 Million National Alzheimers Disease Research Center - Newswise

Neuroscience

BioXcel Therapeutics Announces Notice of Allowance for US Patent Application Covering Formulation for BXCL501 and Methods of Treating AgitationPatent…

NEW HAVEN, Conn., July 07, 2020 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (BTI or Company) (Nasdaq: BTAI), a clinical-stage biopharmaceutical company utilizing artificial intelligence to identify improved therapies in neuroscience and immuno-oncology, today announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for patent application No. 16/453,679 related to BXCL501, the Companys proprietary sublingual thin-film formulation of dexmedetomidine (Dex). The patent is expected to cover film formulations containing Dex and methods of treating agitation using such film formulations.

The allowance of this patent substantially strengthens our intellectual property position, an important milestone for BXCL501s development and potential commercialization, commented Vimal Mehta, Ph.D., Chief Executive Officer of BTI. With a significant need for an effective therapy that addresses the underlying cause of agitation, BXCL501 has the potential to fill this gap, while also providing a unique and favorable delivery method for treating patients. As we prepare to report topline data from our pivotal SERENITY trials this month, we are thrilled to have received this patent allowance for film formulations containing Dex, an essential step in creating value for our shareholders.

A Notice of Allowance is issued after the USPTO makes a determination that a patent should be granted from an application. The patent, which is expected to be issued in the third quarter of 2020, will have a term that expires no earlier than 2039. After issuance, BioXcel plans to list the U.S. patent in the FDA's Approved Drug Products with Therapeutic Equivalence Evaluations, or Orange Book.

About BXCL501

BXCL501 is a potential first-in-class, proprietary sublingual thin film of dexmedetomidine, a selective alpha-2a receptor agonist for the treatment of acute agitation. BTI believes that BXCL501 directly targets a causal agitation mechanism and the Company has observed anti-agitation effects in clinical studies across multiple neuropsychiatric indications. BXCL501 has also been granted Fast Track Designation by the U.S. Food and Drug Administration for the acute treatment of mild to moderate agitation in schizophrenia, bipolar disorder, and dementia.

A Phase 1b safety and efficacy study of BXCL501 yielded positive dose-response data. BXCL501 is being evaluated in the SERENITY program, consisting of two Phase 3 studies for the acute treatment of agitation in patients with schizophrenia (SERENITY I) and bipolar disorder (SERENITY II). BXCL501 is also being evaluated in the Phase 1b/2 TRANQUILITY trial for the treatment of agitation associated with dementia, as well as the Phase 1b/2 RELEASE trial for the treatment of opioid withdrawal symptoms.

About BioXcel Therapeutics, Inc.

BioXcel Therapeutics, Inc. is a clinical stage biopharmaceutical company focused on drug development that utilizes artificial intelligence to identify improved therapies in neuroscience and immuno-oncology. BTI's drug re-innovation approach leverages existing approved drugs and/or clinically evaluated product candidates together with big data and proprietary machine learning algorithms to identify new therapeutic indices. BTI's two most advanced clinical development programs are BXCL501, an investigational sublingual thin film formulation in development for acute treatment of agitation resulting from neuropsychiatric disorders, and BXCL701, an investigational orally administered systemic innate immunity activator in development for treatment of a rare form of prostate cancer and for treatment of pancreatic cancer in combination with other immuno-oncology agents. For more information, please visit http://www.bioxceltherapeutics.com.

Forward-Looking Statements

This press release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements in this press release include but are not limited to receipt of patent approval for BXCL501, the Companys intellectual property strategy, the timing and data from clinical development initiatives and trials for BXCL501, the potential commercialization of BXCL501 and BTIs corporate strategy. When used herein, words including anticipate, being, will, plan, may, continue, and similar expressions are intended to identify forward-looking statements. In addition, any statements or information that refer to expectations, beliefs, plans, projections, objectives, performance or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking.

These forward-looking statements are based on managements current expectations and beliefs. These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause BTIs actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including, but not limited to, the following: its limited operating history; its incurrence of significant losses; its need for substantial additional funding and ability to raise capital when needed; its limited experience in drug discovery and drug development; its dependence on the success and commercialization of BXCL501 and BXCL701 and other product candidates; the failure of preliminary data from its clinical studies to predict final study results; failure of its early clinical studies or preclinical studies to predict future clinical studies; its ability to receive regulatory approval for its product candidates; its ability to enroll patients in its clinical trials; undesirable side effects caused by BTIs product candidates; its approach to the discovery and development of product candidates based on EvolverAI is novel and unproven; its exposure to patent infringement lawsuits; its ability to comply with the extensive regulations applicable to it; impacts from the COVID-19 pandemic; its ability to commercialize its product candidates; and the other important factors discussed under the caption Risk Factors in its Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2020, as such factors may be updated from time to time in its other filings with the SEC, which are accessible on the SECs website at http://www.sec.gov and Investors sections of our website at http://www.bioxceltherapeutics.com.

These and other important factors could cause actual results to differ materially from those indicated by the forward-looking statements made in this press release. Any such forward-looking statements represent managements estimates as of the date of this press release. While BTI may elect to update such forward-looking statements at some point in the future, except as required by law, it disclaims any obligation to do so, even if subsequent events cause its views to change. These forward-looking statements should not be relied upon as representing BTIs views as of any date subsequent to the date of this press release.

Contact Information:BioXcel Therapeutics, Inc.www.bioxceltherapeutics.com

Investor Relations:John Grazianojgraziano@troutgroup.com1.646.378.2942

Media:Julia Deutschjdeutsch@troutgroup.com1.646.378.2967

Read more from the original source:
BioXcel Therapeutics Announces Notice of Allowance for US Patent Application Covering Formulation for BXCL501 and Methods of Treating AgitationPatent...

Neuroscience

Wickham ’21 Speaks on the Black Student Experience in STEM – Wesleyan Connection

As the Black Lives Matter movement continues to shine a light on the Black experience in America, one Wesleyan student is doing his part to foster better understanding for students of color in STEM fields.

On July 2, Fitzroy Pablo Wickham 21 participated in a panel discussion on Black Lives Matter and Neuroscience: Why This Moment Matters. The event, hosted by the Society for Neuroscience and moderated by Trinity College President Joanne Berger-Sweeney, provided a forum to discuss hurdles faced by Black students and faculty in STEM and ways to enhance recruitment, mentoring, and retention in STEM fields.

Wickham, a neuroscience and theater double major, is the Class of 2021 president and a College of Integrative Sciences summer research student. A native of Jamaica, Wickham prefaced his comments by acknowledging that as a West Indian Black his experience does not necessarily reflect the full breadth of experiences had by African American students in science. But for his part, Wickham hopes that in sharing his perspective as a neuroscience undergraduate, he can help move the conversation forward in terms of how we can make the field more inclusive and equitable and in particular to voice some of the challenges Black students encounter when navigating STEM.

Although the panel was convened to discuss issues faced by Black students and faculty in the field of neuroscience, the topics addressed stretched beyond scientific disciplines, touching on issues that affect people of color in all aspects of academia, including lack of representation, the misperception that rewards are dispensed based on race rather than merit, and questions of tokenism. Over the course of the hourlong panel, participants talked about their own experiences, the obstacles they themselves had faced in their varied career paths, and the individuals who had helped to mentor them and advocate for them along the way.

Nii Addy, associate professor of psychiatry at Yales School of Medicine, encouraged participants to look outside their individual departments for mentorship and support when there are few available options in their own field and said that he, himself, makes mentoring others and connecting individuals with potential mentors a priority.

Marguerite Matthews, a health program specialist in the Office of Programs to Enhance Neuroscience Workforce Diversity at the National Institute of Neurological Disorders and Stroke (NINDS), works on diversity initiatives and programs that provide research training and career development opportunities for students from underrepresented backgrounds. She emphasized the need for academia to work in tandem with government programs to make sure underrepresented students and faculty are getting the necessary support to create an equitable situation with their peers, citing the importance of seeing diversity as something that is not an add-on. It is not an extra, not a bonus, not something special that you are doing. It is something that should be considered through every single process.

Fitzroy Pablo Wickham 21 is a neuroscience and theater double major, president of the Class of 2021, and a College of Integrative Sciences summer intern.

When asked about signs of progress and change, Wickham noted Wesleyans public support of the Black Lives Matter movement and encouraged the University to continue moving forward by supporting Black businesses and by setting a new standard for action among peer institutions.

Although the panel didnt necessarily have solutions for every issue brought up during the discussion and Q&A, Wickham did find the overall discussion itself to be a powerful first step.

This conversation is so important to so many people. I was overwhelmed by the number of registrants for the webinarboth in America and internationally, he said. The BLM movement has the undivided attention of the world right now and people are listening. These discussions are needed! The many questions posed by the attendees were very thought-provoking and show that we need more opportunities like this to hash out the matter and figure out how we will move forward, because one hour is not enough.

Link:
Wickham '21 Speaks on the Black Student Experience in STEM - Wesleyan Connection

Neuroscience

New Study Examines Recursive Thinking – ScienceBlog.com

Recursion the computational capacity to embed elements within elements of the same kind has been lauded as the intellectual cornerstone of language, tool use and mathematics. A multi-institutional team of Carnegie Mellon University researchers, for the first time, show this ability is shared across age, species and cultural groups in a new study published in the June 26 issue of the journal Science Advances.

Recursion is a way to organize information that allows humans to see patterns in information that are rich and complex, and perhaps beyond what other species see, saidJessica Cantlon, the Ronald J. and Mary Ann Zdrojkowski Professor of Developmental Neuroscience at CMU and senior author on the paper. We try to trace the origins of our complex and rich intellectual activities to something in our evolutionary past to understand what makes our thinking similar to and distinct from other species.

The team set up a series of experiments with U.S. adults, adults from an indigenous group in Bolivia that largely lacks formal education, U.S. children and non-human primates. After training on the task, the researchers provided each group with sequences to order. They studied how each group conducted this task, either in a recursive or non-recursive way (listing) and looked to see which order they naturally chose.

The researchers found that the human participants from all age and cultural groups spontaneously ordered content from a recursive approach by building nested structures. The non-human primate subjects more commonly used a simpler listing strategy but with additional exposure began using the recursive strategy, eventually ending up in the range of performance of human children.

This ability to represent recursive structures is present in children as young as three years old, which suggests it is there even before they use it in language, said Stephen Ferrigno, a post-doctoral fellow at Harvard University and first author on the paper. We also saw this ability across people from widely different human cultures. Non-human primates also have the capacity to represent recursive sequences, given the right experience. These results dispel the long-held belief that only humans have the capacity to use this rule.

The team found that working memory was an important factor affecting the sequencing abilities of participants. A strong correlation exists between working memory and the use of the hierarchical strategy.

Some of the errors were due to working memory, because participants had to remember which objects went first and relate that to other objects later in the list, said Ferrigno. Children and non-human primates had more errors, which may be due to lower working memory capacity.

The authors note that this work offers a simplified version of a recursive task using visual cues. A more complex series of tasks may not yield the same results.

There is something universal of being a human that lets our brains think this way spontaneously, but primates have the ability to learn it to some degree, said Cantlon. [This research] really gives us a chance to sort out the evolutionary and developmental contributions to complex thought.

Cantlon and Ferrigno were joined by Samuel Cheyette and Steven Piantadosi at the University of California, Berkeley on the study titled, Recursive sequence generation in monkeys, children, US adults, and native Amazonians. This work received support from the National Science Foundation, the National Institutes of Health, the James S. McDonnell Foundation, the Alfred P. Sloan Foundation and the University of Rochester.

Continue reading here:
New Study Examines Recursive Thinking - ScienceBlog.com

Neuroscience

How neuro-knowledge can help us find happiness and improve mental health – ABC News

Happiness doesn't just happen.

Neuroscience tells us happiness is like a muscle that needs to be exercised, tested and toned if we are going to make the most of it.

In troubled and uncertain times, like many have experienced through the coronavirus pandemic, that means making opportunities to put your happiness muscles through their paces.

Advice from experts in personal brain training can also help break down the science and psychology behind mental health challenges.

Loading...

Practice uncertainty and seek out moments of joy

Set up schedules or daily routines theyre your secret weapon against worry and uncertainty.

A daily gratitude journal is an easy way to help identify and lock in your positive emotions.

"Fear of the unknown is perhaps the fundamental worry that underlies all our very human anxieties in 2020, many of us have been scrambling to find ways to cope with emotional turmoil," neuroscientist Sarah McKay said.

"We vary in our tolerance to uncertainty; some people are OK with not knowing what the future holds, others struggle to deal with even the smallest degree of doubt.

"The good news is tolerance to uncertainty is like a muscle and it can be strengthened."

Dr McKay is an educator and author who uses her neuro-knowledge to offer practical advice on better mental health and wellbeing.

She said taking small, positive steps was critical in a year of bushfires and now COVID-19 that has tested our collective sense of security and wellbeing.

"Control what you can, so set up schedules or daily routines they're your secret weapon against worry," she said.

"Secondly, now, more than ever, it's important to find joy in the small things and to wallow in moments of pleasure.

"Schedule indulgences that you can look forward to. People who do this experience more motivation, sense of purpose and most importantly, improved mood."

Dr McKay said keeping a daily gratitude journal was one easy way to help identify and lock in positive emotions.

Loading...

Get connected

Humans are social creatures who rely on each other for survival. We're wired to connect but it can take a conscious effort to make it happen.

We thrive when we're together and we are happier and healthier when we make the time to connect.

Since long before the arrival of COVID-19, Danielle Einstein has been researching our intuitive responses to uncertainty.

She is a clinical psychologist specialising in the treatment and prevention of anxiety.

While Dr Einstein agrees that positive psychology is important, she said understanding the cycle of negative thoughts would also help when learning how best to flex your happiness muscles.

Loading...

Smell the roses or sample a sunset

Moving your body through the natural world is one of the easiest ways to improve mood or even lift depression.

Make time for nature during your week visit the beach in the morning, do a bushwalk on the weekend, or just spend time in the garden.

"When we experience uncertainty in an area that is important to us, at the back of our mind we have thoughts about the worst possible outcome," she said.

"I call these types of thoughts uncertainty bombs they circle around and bother us.

"We can't help it, it's our tendency to look out for danger to protect ourselves."

Dr Einstein said she believed knowledge was the key to defusing uncertainty bombs or at least to limit their damage.

"Learning how uncertainty bombs derail us and how we have the power to recognise, manage and step out of the what-if spiral, will help lower anxiety levels."

Loading...

Breathe, just breathe

Minimising stress is a crucial step, and something simple we can all learn is how to use our breath to regulate the body's response to tension.

A simple exercise is the double inhale: take one breath through the nostrils, then a second ... now, slowly exhale.

Health experts say connecting with friends and community is one of the most important ways to improve your mental health, particularly in times of COVID-19 with so much forced isolation.

Dr McKay said spending time with other people, thinking about what they were thinking, feeling what they were feeling, even holding a conversation, was one of the most cognitively important functions of the brain.

"Humans are first and foremost social creatures who rely on each other for survival," she said.

"We're wired to connect, but it can take a conscious and determined effort to make it happen.

"We thrive when we're together and we are happier and healthier when we make the time to connect."

Loading...

Sleep well, eat well

Modern humans are chronically sleep deprived, which can impact cognition, mood, memory and learning, so a regular good-night's sleep should be a priority, not a luxury.

Studies by Deakin University are also helping us better understand the important relationship between the food we eat, our brain, gut and mental health.

Sunshine, light and fresh air are nature's ways of helping us chill out and gain perspective.

Moving your body through the natural world is one of the most practical ways to improve mood or even combat depression.

Dr McKay said new research suggested looking at panoramic vistas such sunsets, horizons, gazing out to sea or at mountain ranges, also regulated our stress responses and triggered happiness reflexes.

"Not only do sunrises and sunsets look beautiful, the colours are an important part of signalling when it's daytime and nightfall and when it's time to sleep, which builds resilience to stress," she said.

"Time in nature helps to improve mood, reduce blood pressure and can increase our ability to concentrate."

Excerpt from:
How neuro-knowledge can help us find happiness and improve mental health - ABC News

Neuroscience

Neuroscience Antibodies and Assays Market Trends 2020-2024 with Opportunities, Challenges and Companies’ Profile | Thermo Fisher, Abcam, Bio-Rad – 3rd…

Competitive Market Research Report on Global Neuroscience Antibodies and Assays Market with focus on Industry Analysis, Growth Opportunities, Risk Analysis, Current Trends, Competitive Landscape, Investment Strategies and Forecast by 2024.

The report contains in-depth information on all the key aspects of the global Neuroscience Antibodies and Assays market. This report contains important data such as facts & figures, market research, market analysis, SWOT analysis, competitive landscape, regional analysis and future growth prospects. The report also contains qualitative and quantitative research which gives you a detailed analysis of the global Neuroscience Antibodies and Assays market. The report is perfect as you can see information on the recent developments, based on which you can make risk assessments and investments in the Neuroscience Antibodies and Assays industry.

Get The Sample Report PDF with Detail TOC & List of [emailprotected]https://marketresearchport.com/request-sample/5148

Leading Companies Covered:

Thermo Fisher, Abcam, Bio-Rad, Merck, Cell Signaling Technology, Genscript, Rockland Immunochemicals, BioLegend, Santa Cruz Biotechnology, Roche, Siemens

This global Neuroscience Antibodies and Assays market research report has data of all the leading players operating in the industry. From their market shares in the industry, to their growth plans, recent development status, all important information has been compiled in the report to let you get an insightful look at the top players operating in the industry. The report includes the forecasts, analysis and discussion of important industry trends, market size, market share estimates and profiles of the leading industry players.

Market Research is Further Divided into Following Segments:

Market Segmentation by Product Types:Consumables, Instruments

Market Segmentation by Applications:Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers

Regions Mentioned in the Global Neuroscience Antibodies and Assays Market:

The Middle East and Africa North America South America Europe Asia-Pacific Middle East Oceania Rest of the World

The data of the market research report has been studied, compiled and corroborated by leading industry experts and established authors. The format followed in the report is in accordance with most international market research reports. However, if you have any specific requirements, just get in touch with us, and we will customize the report accordingly as per your needs.

Do Enquiry For Customized Report as per Your [emailprotected]https://marketresearchport.com/enquiry-before-buying/5148

Table of Content:1 Industry Overview of Neuroscience Antibodies and Assays1.1 Brief Introduction of Neuroscience Antibodies and Assays1.1.1 Definition of Neuroscience Antibodies and Assays1.1.2 Development of Neuroscience Antibodies and Assays Industry1.2 Classification of Neuroscience Antibodies and Assays1.3 Status of Neuroscience Antibodies and Assays Industry1.3.1 Industry Overview of Neuroscience Antibodies and Assays1.3.2 Global Major Regions Status of Neuroscience Antibodies and Assays

2 Industry Chain Analysis of Neuroscience Antibodies and Assays2.1 Supply Chain Relationship Analysis of Neuroscience Antibodies and Assays2.2 Upstream Major Raw Materials and Price Analysis of Neuroscience Antibodies and Assays2.3 Downstream Applications of Neuroscience Antibodies and Assays

3 Manufacturing Technology of Neuroscience Antibodies and Assays3.1 Development of Neuroscience Antibodies and Assays Manufacturing Technology3.2 Manufacturing Process Analysis of Neuroscience Antibodies and Assays3.3 Trends of Neuroscience Antibodies and Assays Manufacturing Technology

4 Major Manufacturers Analysis of Neuroscience Antibodies and Assays4.1 Company 14.1.1 Company Profile4.1.2 Product Picture and Specifications4.1.3 Capacity, Production, Price, Cost, Gross and Revenue4.1.4 Contact Information4.2 Company 24.2.1 Company Profile4.2.2 Product Picture and Specifications4.2.3 Capacity, Production, Price, Cost, Gross and Revenue4.2.4 Contact Information4.3 Company 34.3.1 Company Profile4.3.2 Product Picture and Specifications4.3.3 Capacity, Production, Price, Cost, Gross and Revenue4.3.4 Contact Information4.4 Company 44.4.1 Company Profile4.4.2 Product Picture and Specifications4.4.3 Capacity, Production, Price, Cost, Gross and Revenue4.4.4 Contact Information4.5 Company 54.5.1 Company Profile4.5.2 Product Picture and Specifications4.5.3 Capacity, Production, Price, Cost, Gross and Revenue4.5.4 Contact Information4.6 Company 64.6.1 Company Profile4.6.2 Product Picture and Specifications4.6.3 Capacity, Production, Price, Cost, Gross and Revenue4.6.4 Contact Information4.7 Company 74.7.1 Company Profile4.7.2 Product Picture and Specifications4.7.3 Capacity, Production, Price, Cost, Gross and Revenue4.7.4 Contact Information4.8 Company 84.8.1 Company Profile4.8.2 Product Picture and Specifications4.8.3 Capacity, Production, Price, Cost, Gross and Revenue4.8.4 Contact Information4.9 Company 94.9.1 Company Profile4.9.2 Product Picture and Specifications4.9.3 Capacity, Production, Price, Cost, Gross and Revenue4.9.4 Contact Information4.10 Company ten4.10.1 Company Profile4.10.2 Product Picture and Specifications4.10.3 Capacity, Production, Price, Cost, Gross and Revenue4.10.4 Contact Information

5 Global Productions, Revenue and Price Analysis of Neuroscience Antibodies and Assays by Regions, Manufacturers, Types and Applications5.1 Global Production, Revenue of Neuroscience Antibodies and Assays by Regions 2014-20195.2 Global Production, Revenue of Neuroscience Antibodies and Assays by Manufacturers 2014-20195.3 Global Production, Revenue of Neuroscience Antibodies and Assays by Types 2014-20195.4 Global Production, Revenue of Neuroscience Antibodies and Assays by Applications 2014-20195.5 Price Analysis of Global Neuroscience Antibodies and Assays by Regions, Manufacturers, Types and Applications in 2014-2019

6 Global and Major Regions Capacity, Production, Revenue and Growth Rate of Neuroscience Antibodies and Assays 2014-20196.1 Global Capacity, Production, Price, Cost, Revenue, of Neuroscience Antibodies and Assays 2014-20196.2 Asia Pacific Capacity, Production, Price, Cost, Revenue, of Neuroscience Antibodies and Assays 2014-20196.3 Europe Capacity, Production, Price, Cost, Revenue, of Neuroscience Antibodies and Assays 2014-20196.4 Middle East & Africa Capacity, Production, Price, Cost, Revenue, of Neuroscience Antibodies and Assays 2014-20196.5 North America Capacity, Production, Price, Cost, Revenue, of Neuroscience Antibodies and Assays 2014-20196.6 Latin America Capacity, Production, Price, Cost, Revenue, of Neuroscience Antibodies and Assays 2014-2019

7 Consumption Volumes, Consumption Value, Import, Export and Sale Price Analysis of Neuroscience Antibodies and Assays by Regions7.1 Global Consumption Volume and Consumption Value of Neuroscience Antibodies and Assays by Regions 2014-20197.2 Global Consumption Volume, Consumption Value and Growth Rate of Neuroscience Antibodies and Assays 2014-20197.3 Asia Pacific Consumption Volume, Consumption Value, Import, Export and Growth Rate of Neuroscience Antibodies and Assays 2014-20197.4 Europe Consumption Volume, Consumption Value, Import, Export and Growth Rate of Neuroscience Antibodies and Assays 2014-20197.5 Middle East & Africa Consumption Volume, Consumption Value, Import, Export and Growth Rate of Neuroscience Antibodies and Assays 2014-20197.6 North America Consumption Volume, Consumption Value, Import, Export and Growth Rate of Neuroscience Antibodies and Assays 2014-20197.7 Latin America Consumption Volume, Consumption Value, Import, Export and Growth Rate of Neuroscience Antibodies and Assays 2014-20197.8 Sale Price Analysis of Global Neuroscience Antibodies and Assays by Regions 2014-2019

8 Gross and Gross Margin Analysis of Neuroscience Antibodies and Assays8.1 Global Gross and Gross Margin of Neuroscience Antibodies and Assays by Regions 2014-20198.2 Global Gross and Gross Margin of Neuroscience Antibodies and Assays by Manufacturers 2014-20198.3 Global Gross and Gross Margin of Neuroscience Antibodies and Assays by Types 2014-20198.4 Global Gross and Gross Margin of Neuroscience Antibodies and Assays by Applications 2014-2019

9 Marketing Traders or Distributor Analysis of Neuroscience Antibodies and Assays9.1 Marketing Channels Status of Neuroscience Antibodies and Assays9.2 Marketing Channels Characteristic of Neuroscience Antibodies and Assays9.3 Marketing Channels Development Trend of Neuroscience Antibodies and Assays

10 Global and Chinese Economic Impacts on Neuroscience Antibodies and Assays Industry10.1 Global and Chinese Macroeconomic Environment Analysis10.1.1 Global Macroeconomic Analysis and Outlook10.1.2 Chinese Macroeconomic Analysis and Outlook10.2 Effects to Neuroscience Antibodies and Assays Industry

11 Development Trend Analysis of Neuroscience Antibodies and Assays11.1 Capacity, Production and Revenue Forecast of Neuroscience Antibodies and Assays by Regions, Types and Applications11.1.1 Global Capacity, Production and Revenue of Neuroscience Antibodies and Assays by Regions 2019-202411.1.2 Global and Major Regions Capacity, Production, Revenue and Growth Rate of Neuroscience Antibodies and Assays 2019-202411.1.3 Global Capacity, Production and Revenue of Neuroscience Antibodies and Assays by Types 2019-202411.2 Consumption Volume and Consumption Value Forecast of Neuroscience Antibodies and Assays by Regions11.2.1 Global Consumption Volume and Consumption Value of Neuroscience Antibodies and Assays by Regions 2019-202411.2.2 Global and Major Regions Consumption Volume, Consumption Value and Growth Rate of Neuroscience Antibodies and Assays 2019-202411.3 Supply, Import, Export and Consumption Forecast of Neuroscience Antibodies and Assays11.3.1 Supply, Consumption and Gap of Neuroscience Antibodies and Assays 2019-202411.3.2 Global Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Neuroscience Antibodies and Assays 2019-202411.3.3 North America Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Neuroscience Antibodies and Assays 2019-202411.3.4 Europe Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Neuroscience Antibodies and Assays 2019-202411.3.5 Asia Pacific Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Neuroscience Antibodies and Assays 2019-202411.3.6 Middle East & Africa Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Neuroscience Antibodies and Assays 2019-202411.3.7 Latin America Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Neuroscience Antibodies and Assays 2019-2024

12 Contact information of Neuroscience Antibodies and Assays12.1 Upstream Major Raw Materials and Equipment Suppliers Analysis of Neuroscience Antibodies and Assays12.1.1 Major Raw Materials Suppliers with Contact Information Analysis of Neuroscience Antibodies and Assays12.1.2 Major Equipment Suppliers with Contact Information Analysis of Neuroscience Antibodies and Assays12.2 Downstream Major Consumers Analysis of Neuroscience Antibodies and Assays12.3 Major Suppliers of Neuroscience Antibodies and Assays with Contact Information12.4 Supply Chain Relationship Analysis of Neuroscience Antibodies and Assays

13 New Project Investment Feasibility Analysis of Neuroscience Antibodies and Assays13.1 New Project SWOT Analysis of Neuroscience Antibodies and Assays13.2 New Project Investment Feasibility Analysis of Neuroscience Antibodies and Assays13.2.1 Project Name13.2.2 Investment Budget13.2.3 Project Product Solutions13.2.4 Project Schedule

14 Conclusion of the Global Neuroscience Antibodies and Assays Industry 2019 Market Research Report

About Us:Market Research Port is one of the best report resellers in the market bringing to you accurate and trustworthy market research reports by reputed publishers. Our trusted publishers have compiled their reports and findings after painstaking research and studies, set up against varied business parameters. Each report is detailed and then vetted for accuracy by industry experts. In each report, you will find deep analysis, risk analysis, market forecasts, emerging trends, different market segments, technological advancement and its impact, and a multitude of economic factors, giving you the most comprehensive market research report. You get many advantages with such comprehensive reports.

Contact Us:Market Research Port,Brighton Street, Providence,Rhode Island 02929, United StatesContact No: +1 401 433 7610Email: [emailprotected]Website: https://marketresearchport.com/

See more here:
Neuroscience Antibodies and Assays Market Trends 2020-2024 with Opportunities, Challenges and Companies' Profile | Thermo Fisher, Abcam, Bio-Rad - 3rd...

Neuroscience

Global Neuroscience Antibodies and Assays Market 2020 With COVID-19 Impact on Company, Regions, Type and Application, Forecast to 2025 – NJ MMA News

Global Neuroscience Antibodies and Assays Market 2020 by Company, Regions, Type and Application, Forecast to 2025carefully researches each trend and the major factors accountable for driving the growth of the Industry. The report largely concentrates on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. The report initially discusses the market definition, market overview, product description, product scope, product characterization, and product specification details. The market dynamics section explores the drivers, restraints, trends, and opportunities of the globalNeuroscience Antibodies and Assaysmarket.

NOTE:Our analysts monitoring the situation across the globe explains that the market will generate remunerative prospects for producers post COVID-19 crisis. The report aims to provide an additional illustration of the latest scenario, economic slowdown, and COVID-19 impact on the overallNeuroscience Antibodies and Assaysindustry.

Get Free Sample Report:https://www.researchstore.biz/sample-request/15046

The factors affecting the leading industry players to adopt sourcing of the market products have also been studied in this comprehensive report. Every organization taking part in the global production of the globalNeuroscience Antibodies and Assaysmarket products have been included in this report. The report aims to study the insights on cost-effective manufacturing methods, competitive landscape, and new avenues for applications. The market report accommodates market drivers and challenges & opportunities for a national level market in the particular provincial sections. It also provides the current industry value according to demand.

Scope of The Report:

The report evaluates investment feasibility, significant return on investment, supply chain management, import and export status, consumption volume, and end-use. All key factors that help business owners identify the next leg for growth are presented through useful resources such as charts, tables, and graphic images. The analysts believe that in the next few years, globalNeuroscience Antibodies and Assaysmarket size will be further expanded, we expect that by 2025, the market will achieve the highest growth.

Following top key players are profiled with global positioning:Thermo Fisher, BioLegend, Merck, Abcam, Rockland Immunochemicals, Bio-Rad, Roche, Genscript, Cell Signaling Technology, Santa Cruz Biotechnology, Siemens

Global market segmentation by regions:North America (United States, Canada and Mexico), Europe (Germany, France, UK, Russia and Italy), Asia-Pacific (China, Japan, Korea, India and Southeast Asia), South America (Brazil, Argentina, etc.), Middle East& Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

The report explains the current state of the market around the world. The report covers the market outline and key components of the globalNeuroscience Antibodies and Assaysmarket which assumes a significant job for clients to settle on the business choice. It focuses on upgrades and development within the global market. By using this report users get a clear perspective on the market conditions, trends, and coming period outlook for various segments. The global market has been segmented on the basis of product type, application, distribution channel, end-user, and industry vertical, along with the geography, delivering valuable insights.

Access Full Report:https://www.researchstore.biz/report/global-neuroscience-antibodies-and-assays-market-15046

The Analysis Objectives of The Report Are:

Total Chapters In This Market Report Are:

Chapter 1:Overview of globalNeuroscience Antibodies and Assaysmarket

Chapter 2:Global growth trends

Chapter 3:Market share by key players

Chapter 4:Breakdown data by type and application

Chapter 5:North America market status by countries, type, manufacturers and downstream industry

Chapter 6:Europe Market status by countries, type, manufacturers and downstream industry

Chapter 7:Asia Pacific market status by countries, type, manufacturers and downstream industry

Chapter 8:South America market status by countries, type, manufacturers and downstream industry

Chapter 9:the Middle East and Africa market status by countries, type, manufacturers and downstream industry

Chapter 10:Market driving factor analysis

Chapter 11:Market competition status by major manufacturers

Chapter 12:International players profiles

Chapter 13:Market Forecast 2020-2025

Chapter 14:Analysts Viewpoints/Conclusions

Chapter 15:Appendix

Customization of the Report:This report can be customized to meet the clients requirements. Please connect with our sales team (sales@researchstore.biz), who will ensure that you get a report that suits your needs. You can also get in touch with our executives on +1-201-465-4211 to share your research requirements.

About Us

Researchstore.biz is a fully dedicated global market research agency providing thorough quantitative and qualitative analysis of extensive market research.Our corporate is identified by recognition and enthusiasm for what it offers, which unites its staff across the world.We are desired market researchers proving a reliable source of extensive market analysis on which readers can rely on. Our research team consist of some of the best market researchers, sector and analysis executives in the nation, because of which Researchstore.biz is considered as one of the most vigorous market research enterprises. Researchstore.biz finds perfect solutions according to the requirements of research with considerations of content and methods. Unique and out of the box technologies, techniques and solutions are implemented all through the research reports.

Contact UsMark StoneHead of Business DevelopmentPhone:+1-201-465-4211Email:sales@researchstore.bizWeb:www.researchstore.biz

Go here to see the original:
Global Neuroscience Antibodies and Assays Market 2020 With COVID-19 Impact on Company, Regions, Type and Application, Forecast to 2025 - NJ MMA News

Neuroscience

Chinese Academy of Science Researcher Accused of Academic Plagiarism – Caixin Global

Whats new: Yang Hui, a researcher at the Chinese Academy of Sciences Institute of Neuroscience, has been accused of academic plagiarism for his study published in the journal Cell in April.

Fu Xiangdong, a professor of cellular and molecular medicine at the University of California, San Diego, reportedly accused Yang of plagiarizing a study on Parkinsons disease that his team submitted to the journal Nature in November 2018, according to a letter (link in Chinese) circulating online. Fus study was published last month.

In response to the controversy, the Institute of Neuroscience said Friday in a statement (link in Chinese) that it will investigate the matter and disclose any findings to the public. In his own statement (link in Chinese) Friday, Yang said hes cooperating with the investigation.

Whats the background: Fu, 63, said in the letter that he had presented the unpublished results and design of his study at a briefing that Yang attended at the Institute of Neuroscience in June 2018. Yang dined with Fu afterward and later consulted him about the study, according to the letter.

According to Cells website, it received Yangs study in August 2019, accepted it in March and published it in April.

Quick Takes are condensed versions of China-related stories for fast news you can use. To read the full Caixin article in Chinese, click here.

Contact reporter Timmy Shen (hongmingshen@caixin.com) and editor Michael Bellart (michaelbellart@caixin.com)

Register to read this article for free.

Register

Read the original here:
Chinese Academy of Science Researcher Accused of Academic Plagiarism - Caixin Global

Neuroscience

Trending News Corona impact on Neuroscience Market Drivers And Restrains, Along With Their Current And Expected Impact Till 2025| GE Healthcare,…

The global Neuroscience Market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global Neuroscience Market. For instance, the market dynamics section digs deep into the drivers, restraints, trends, and opportunities of the global Neuroscience Market. With qualitative and quantitative analysis, we help you with thorough and comprehensive research on the global Neuroscience Market. We have also focused on SWOT, PESTLE, and Porters Five Forces analyses of the global Neuroscience Market.

Leading players of the global Neuroscience Market are analyzed taking into account their market share, recent developments, new product launches, partnerships, mergers or acquisitions, and markets served. We also provide an exhaustive analysis of their product portfolios to explore the products and applications they concentrate on when operating in the global Neuroscience Market. Furthermore, the report offers two separate market forecasts one for the production side and another for the consumption side of the global Neuroscience Market. It also provides useful recommendations for new as well as established players of the global Neuroscience Market.

Final Neuroscience Report will add the analysis of the impact of COVID-19 on this Market.

Neuroscience Market competition by top manufacturers/Key player Profiled:GE Healthcare, Siemens Healthineers, Noldus Information Technology, Mightex Bioscience, Thomas RECORDING GmbH, Blackrock Microsystems, Tucker-Davis Technologies, Plexon, Phoenix Technology Group, NeuroNexus, Alpha Omega

Request for Sample Copy of This Report @https://www.reporthive.com/request_sample/2298403

the Global Neuroscience Market is estimated to reach xxx million USD in 2020 and projected to grow at the CAGR of xx% during the 2021-2026. The report analyses the global Neuroscience market, the market size and growth, as well as the major market participants.

Segmentation by Product:Whole Brain Imaging, Neuro-Microscopy, Electrophysiology Technologies, Neuro-Cellular Manipulation, Stereotaxic Surgeries, Animal Behavior, Others

Segmentation by Application:Hospitals, Diagnostic Laboratories, Research Institutes, Others

Competitive Analysis:

Global Neuroscience Market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of Neuroscience Market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Scope of the Report:The all-encompassing research weighs up on various aspects including but not limited to important industry definition, product applications, and product types. The pro-active approach towards analysis of investment feasibility, significant return on investment, supply chain management, import and export status, consumption volume and end-use offers more value to the overall statistics on the Neuroscience Market. All factors that help business owners identify the next leg for growth are presented through self-explanatory resources such as charts, tables, and graphic images.

Key Questions Answered:

Our industry professionals are working reluctantly to understand, assemble and timely deliver assessment on impact of COVID-19 disaster on many corporations and their clients to help them in taking excellent business decisions. We acknowledge everyone who is doing their part in this financial and healthcare crisis.

For Customised Template PDF Report:https://www.reporthive.com/request_customization/2298403

Table of Contents

Report Overview:It includes major players of the global Neuroscience Market covered in the research study, research scope, and Market segments by type, market segments by application, years considered for the research study, and objectives of the report.

Global Growth Trends:This section focuses on industry trends where market drivers and top market trends are shed light upon. It also provides growth rates of key producers operating in the global Neuroscience Market. Furthermore, it offers production and capacity analysis where marketing pricing trends, capacity, production, and production value of the global Neuroscience Market are discussed.

Market Share by Manufacturers:Here, the report provides details about revenue by manufacturers, production and capacity by manufacturers, price by manufacturers, expansion plans, mergers and acquisitions, and products, market entry dates, distribution, and market areas of key manufacturers.

Market Size by Type:This section concentrates on product type segments where production value market share, price, and production market share by product type are discussed.

Market Size by Application:Besides an overview of the global Neuroscience Market by application, it gives a study on the consumption in the global Neuroscience Market by application.

Production by Region:Here, the production value growth rate, production growth rate, import and export, and key players of each regional market are provided.

Consumption by Region:This section provides information on the consumption in each regional market studied in the report. The consumption is discussed on the basis of country, application, and product type.

Company Profiles:Almost all leading players of the global Neuroscience Market are profiled in this section. The analysts have provided information about their recent developments in the global Neuroscience Market, products, revenue, production, business, and company.

Market Forecast by Production:The production and production value forecasts included in this section are for the global Neuroscience Market as well as for key regional markets.

Market Forecast by Consumption:The consumption and consumption value forecasts included in this section are for the global Neuroscience Market as well as for key regional markets.

Value Chain and Sales Analysis:It deeply analyzes customers, distributors, sales channels, and value chain of the global Neuroscience Market.

Key Findings: This section gives a quick look at important findings of the research study.

About Us:Report Hive Research delivers strategic market research reports, statistical surveys, industry analysis and forecast data on products and services, markets and companies. Our clientele ranges mix of global business leaders, government organizations, SMEs, individuals and Start-ups, top management consulting firms, universities, etc. Our library of 700,000 + reports targets high growth emerging markets in the USA, Europe Middle East, Africa, Asia Pacific covering industries like IT, Telecom, Semiconductor, Chemical, Healthcare, Pharmaceutical, Energy and Power, Manufacturing, Automotive and Transportation, Food and Beverages, etc. This large collection of insightful reports assists clients to stay ahead of time and competition. We help in business decision-making on aspects such as market entry strategies, market sizing, market share analysis, sales and revenue, technology trends, competitive analysis, product portfolio, and application analysis, etc.

Contact Us:

Report Hive Research

500, North Michigan Avenue,

Suite 6014,

Chicago, IL 60611,

United States

Website: https://www.reporthive.com

Email: [emailprotected]

Phone: +1 312-604-7084

Follow this link:
Trending News Corona impact on Neuroscience Market Drivers And Restrains, Along With Their Current And Expected Impact Till 2025| GE Healthcare,...

Neuroscience

Far From Home: Oregon The Clarion – Clarion

A quick look at new Bethel arrivals from across the nation and overseas.

By Rachel Blood

This week, the Clarion spoke to incoming freshman Joshua Hahn about his journey from Canada to Oregon and how he discovered a small midwestern campus from Portland. Joshua is a neuroscience major and has been playing piano for twelve years.

Q&A: Joshua Hahn (OR)

Q: Where you were born, where did you grow up, and where do you live now?

A: I was born in Toronto, Canada, but moved straight to Portland, Oregon, and have lived here ever since.

Q: How did you first hear about Bethel?

A: I heard about Bethel through a Bethel alum. The head of the board of Bethel Alumni actually goes to my church, and they recommended the school to me.

Q: What made you choose to attend school so far from home?

A: I visited multiple schools and Bethel just felt like home. I wanted to attend a school farther from home so I could be independent and relatively self-supported.

Q: What do you plan to study at Bethel?

A: Im hoping to major in neuroscience and maybe minor in music.

Q: Do you plan on playing sports or being involved in music or theater at Bethel?

A: I definitely will be involved in music at Bethel. I plan on being in the orchestra or an ensemble as well as the Bethel worship team (like Vespers or something).

Like Loading...

The rest is here:
Far From Home: Oregon The Clarion - Clarion